Opioid dependence is a public health epidemic.
The number of opioid overdose deaths hit an all-time high in 2014. This includes both prescription pain medications and heroin. Currently one person dies in the US from an opioid overdose every 20 minutes. While there are effective treatment options, these are too often not available to patients when and where they need them. Primary Care providers are on the front lines and in a position to change this. However, we know that physicians do not feel prepared to address these issues and often feel frustrated.
This course seeks to improve knowledge, attitudes and confidence around treating patients with substance use disorders. The course will use lectures, case discussion, work- shops and patient narratives. Topics will include the neurobiological basis of substance use disorders, current trends and research in the field, updates on marijuana and benzodiazepine dependence, as well as detailed looks into alcohol and opioid use disorders. We will learn about the evidence based and FDA approved medication options for alcohol and opioid use disorders that can be prescribed safely in a primary care setting. Course experts include leading clinicians, researchers, policy and public health officials in the field of addiction medicine. Teaching methods include lectures, case presentation, panel discus- sion, patient panel, and question and answer with faculty.
Opioids, Alcohol and Other Drugs in Primary Care: What Can We Do?
Friday, May 12, 2017
Virginia Mason • Seattle, Washington
Optional ASAM Buprenorphine Training
Friday, May 13, 2017
Saturday, May 13
On Saturday at this same location, the American Society of Addiction Medicine will offer a complimentary Buprenorphine Waiver Training course for providers interested in seeking their waiver to prescribe buprenorphine in office-based treatment of opioid use disorders. The course is split into an online portion and the in-person portion. Attendees are expected to complete the online portion of the course before attending the in-person training. To enroll in this free course, email firstname.lastname@example.org or contact the Virginia Mason CME department for details.
Target audience: This course is appropriate for physicians and advanced practice providers in general practice, internal medicine and family care.
Objectives: At the conclusion of this activity, participants should be able to: • Recommend new strategies and treatments for opioid dependent patients • Consider how fear of stigma affects patients with substance dependencies • Review epidemiology and screening tools
• Cite current evidence on chronic benzodiazepine use and utilize tools in discussions with patients
• Recognize what opioid use disorders look like in primary care
• Identify and decrease barriers to offering treatment
• Summarize pain management approaches and plan strategies for discussing options with patients
• Describe current projects and initiatives in Seattle and Washington State • Evaluate current questions and expert opinions around marijuana use
• Integrate SBIRT skills into practice
• Construct and apply skills for successful opioid taper
• Recognize and gain insight into process around impaired physicians
Elenore P. Bhatraju, MD, MPH Adult Primary Care, Department of Internal Medicine
Virginia Mason Federal Way Medical Center, Federal Way, Wash.
Nancy Connolly, MD, MPH Adult Primary Care, Department of Internal Medicine Virginia Mason Lynnwood Medical Center, Lynnwood, Wash.
Karina K. Uldall, MD, MPH Medical Director, Behavioral Health
Virginia Mason Seattle Medical Center, Seattle, Wash.
Phillip Coffin, MD, MIA Director of Substance Use Research, Center for Public Health Research San Francisco Department of Public Health, San Francisco, Calif.
James R. Babington, MD Medical Co-Director, Comprehensive Spine Program
Neurosciences Institute, Section of Physical Medicine & Rehabilitation Virginia Mason Medical Center, Seattle, Wash.
Chris Bundy, MD, MPH Medical Director, Washington Physicians Health Program Clinical Assistant Professor of Psychiatry
University of Washington School of Medicine, Seattle, Wash.
Molly Carney, PhD, MBA Executive Director, Evergreen Treatment Services, Seattle, Wash.
Christopher W. Dunn, PhD Professor, Department of Psychiatry and Behavioral Sciences University of Washington School of Medicine
Harborview Medical Center, Seattle, Wash.
Brad Finegood, MA, LMHC Assistant Division Director
Acting RSN Administrator, Prevention and Treatment Coordinator King County Department of Community and Human Services (DCHS) Behavioral Health and Recovery Division (BHRD), Seattle, Wash.
Jennifer D. Kelly, PsyD Section of Physical Medicine & Rehabilitation Virginia Mason Medical Center, Seattle, Wash.
Joseph Merrill, MD, MPH Associate Professor, Medicine
University of Washington School of Medicine
Adult Medicine, Harborview Medical Center, Seattle, Wash.
Andrew J. Saxon, MDProfessor, Department of Psychiatry and Behavioral Sciences, University of Washington Director, Center of Excellence in Substance Abuse Treatment and Education (CESATE) VA Puget Sound Health Care System
Director, Addiction Psychiatry Residency ProgramUniversity of Washington, Seattle, Wash.
Ananth K. Shenoy, MD General Internal Medicine
Virginia Mason Medical Center, Seattle, Wash.
Judith Tsui, MD, MPH Associate Professor, Medicine
University of Washington School of Medicine Division of General Internal Medicine Harborview Medical Center, Seattle, Wash.